Scaffold Design, Function and Over-expression of Lentiviral-based microRNAs
Poster Aug 25, 2015
Angela Schoolmeesters, Melissa L. Kelley, Annaleen Vermeulen, Anja Smith, *Mayya Shveygert, *Xin Zhou, *Robert Blelloch Dharmacon, now part of GE Healthcare, 2650 Crescent Drive, Suite #100, Lafayette, CO 80026, USA
MicroRNAs are short non-coding RNAs that regulate gene expression through targeted degradation of one or more genes and have been shown to play an important role in development, differentiation and disease. For example, microRNAs are critical for stem cell function and differentiation. Also, dysregulation of microRNA expression has been associated with the development and progression of many types of cancers. To better understand the functional roles of microRNAs in phenotypes of interest, gain-of-function experiments can be performed by introducing microRNA mimics into cells, which mirror the effects of endogenous microRNAs. Studies with synthetic microRNA mimics are useful in easy-to-transfect cell types as well as instances where phenotypes are readily observed over short time periods. However, additional delivery strategies are required for cells that are refractory to transfection and for phenotypes that develop over longer time points. Here we describe the strategy for scaffold design and highlight the importance of choosing an optimal promoter in cells of interest for the over-expression of lentiviral-based microRNA mimics. We demonstrate down-regulation of gene targets in difficult-to-transfect primary, immune and neuronal cells (HuVEC, K562, SH-SY5Y), and show mesenchymal to epithelial transition markers in MDA-MB-231 breast cancer cells by over-expression of miR-429.
Inhibition of The Auto-inflammation Suppressor Protein ISG15 Triggers Preeclampsia by Blocking Trophoblast Migration and InvasionPoster
In summary, ISG15 expression levels are crucial for trophoblast morphology and function (migration/invasion). By blocking trophoblast invasion, reduced ISG15 levels could contribute to impaired spiral artery transformation that reduces utero-placental blood flow in preeclampsia. Thus, agents inducing ISG15 expression are likely to be therapeutic in preeclampsia.
An Emerging Phenotype of Partial RAG 1/2 Deficiency Among Young Children with Autoimmunity and Viral InfectionsPoster
We describe the natural history of a cohort of 12 patients with confirmed partial RAG1/2 mutations and autoimmunity at a young age. We were seeking the link between viral infections and autoimmunity and tested candidate biomarkers that may reflect the underlying RAG1/2 protein deficiency.READ MORE
Complete alignment identification of CRISPR-Cas9 genomic off-targets using Edit-R CRISPR specificity tool and a comprehensive analysis of positional mismatch tolerancePoster
A web tool that performs complete crRNA specificity checking is introduced. In addition, we evaluated positional off-targeting of the CRISPR system.READ MORE